Skip to main content

Advertisement

Table 1 Clinico-pathological characteristics of the patients

From: Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy

  n Percent
Grade   
 2 10 14
 3 62 86
Stage (FIGO)   
 II 3 4
 III 59 82
 IV 10 14
Peritoneal carcinomatosis   
 No 8 11
 Yes 64 89
Residual macroscopic tumor rest   
 No 52 72
 Yes 20 28
Primary platinum sensitivity*   
 Sensitive 48 67
 Resistant 24 33
  1. *Platinum sensitivity is defined as relapse-free survival for at least six months after the end of initial platinum-based chemotherapy